Approved Study Database

Ref. No. Scientific Title Principal investigator
2016.318 Cerebral white matter hyperintensities, connectivity disruption and cortical thinning in elderly with small vessel disease Prof. MOK Vincent Chung Tong
莫仲棠
2017.109 Plasma microRNA dysregulation for the identification of smal vessel disease Prof. MOK Vincent Chung Tong
莫仲棠
2016.099 Enhanced External Counterpulsation for Cerebral Confluent White Matter Hyperintensities Prof. MOK Vincent Chung Tong
莫仲棠
2017.621 A novel imaging marker facilitates early identification of small vessel disease Prof. MOK Vincent Chung Tong
莫仲棠
2017.576 An alternative method to identify cerebral small vessel disease using retinal vascular imaging Prof. MOK Vincent Chung Tong
莫仲棠
2015.682 A PHASE III, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP, EFFICACY AND SAFETY STUDY OF CRENEZUMAB IN PATIENTS WITH PRODROMAL TO MILD ALZHEIMER’S DISEASE Prof. MOK Vincent Chung Tong
莫仲棠
2014.360 Burden, distress and quality of life and moderating effects of mental flexibility and personality traits in caregivers of patients with Frontotemporal Lobar Degeneration Prof. MOK Vincent Chung Tong
2017.254 Identifying biomarkers in Alzheimer’s disease Prof. MOK Vincent Chung Tong
莫仲棠
2016.176 A prospective cohort study: The use of iPhone ECG monitoring in acute ischemic stroke during hospitalization in Hong Kong Prof. MOK Vincent Chung Tong
莫仲棠
2017.337 Impact of oculomotor deficits on dynamic visual functions in Parkinson's Disease Prof. MOK Vincent Chung Tong
莫仲棠
2014.362 A retrospective cross-sectional study of different types of Traditional Chinese Medicine for post-stroke rehabilitation in Hong Kong Prof. MOK Vincent Chung Tong
2009.032 Neuroimaging Predictors for Cognitive Impairment in Chinese Patients with Confluent White Matter Lesion Prof Mok Vincent Chung Tong
2011.090 Risk index for screening subclinical brian lesions in communitydwelling elderly persons in Hong Kong Prof. MOK Vincent Chung Tong
2008.240 A Pilot Study Using Pittsburg Compound-B Positron Emission Tomography in the Evalulation of Poststroke Dementia Prof Mok Vincent Chung Tong
2014.023 Hong Kong Registry of Early Onset Dementia Prof. MOK Vincent Chung Tong
2009.530 Efficacy of Rivastigmine Transdermal Patch in Dementia Patients who do not benefit from Oral Acetylcholinesterase Inhibitors (AChIs) Prof Mok Vincent Chung Tong
2010.540 Transcranial Doppler Ultrasound for Detection of Cerebral White Matter Changes in High-Risk Population Prof Mok Vincent Chung Tong
2011.406 Adaptation of the Booklet Category Test in Chinese: A pilot study Prof MOK Vincent Chung Tong
2009.495 Early Identificaion of significant subclinical brain lesions in community-dwelling elderly persons in Hong Kong Prof Mok Vincent Chung Tong
2013.025 Cilostazol and Cerebral Haemodynamics in Cerebral Small Vessel Disease Prof. Mok Vincent Chung Tong
2011.238 Comparative assessment of difference in reward processing of the brain among normal subjects, stroke patients and major depressive disorder patients Prof. MOK Vincent Chung Tong
2013.433 Development of normative data for NINDS - Canadian Stroke Network Vascular Cognitive Impairment Neuropsychology Protocols Prof. MOK Vincent Chung Tong
2020.194 Effectiveness of oculomotor training on dynamic vision and functional performance in Parkinson’s disease – A randomized clinical trial Prof. MOK Vincent Chung Tong
莫仲棠
2018.615 Follow-up study of a cuffless blood pressure monitoring device for dementia evaluation (Phase II) Prof. MOK Vincent Chung Tong
莫仲棠
2019.350 Comprehensive Analysis Of Molecular, Structural And Functional Biomarkers For Alzheimer's Disease In The Chinese Population (UAD) Prof. MOK Vincent Chung Tong
莫仲棠
2019.391 Transcranial Pulse Stimulation (TPS) for Neurological diseases Pilot study Prof. MOK Vincent Chung Tong
莫仲棠
2018.334 A MULTICENTER, OPEN-LABEL, LONG-TERM EXTENSION OF PHASE III STUDIES (BN29552/BN29553) OF CRENEZUMAB IN PATIENTS WITH ALZHEIMER’S DISEASE Prof. MOK Vincent Chung Tong
莫仲棠
2019.147 Imaging, clinical and other biomakers of small vessel disease (ICOS) Prof. MOK Vincent Chung Tong
莫仲棠
2020.374 Longitudinal follow up study of patients with Alzheimer’s disease using advanced multiparametric MR imaging Prof. MOK Vincent Chung Tong
莫仲棠
2020.620 A Phase 3, multi-center, randomized, double-blind, parallel-group, placebo-controlled clinical trial to evaluate the efficacy and safety of sodium oligomannate (GV-971) in treatment of mild to moderate Alzheimer’s disease (GREEN MEMORY: GREen Valley 971 EvaluatioN Memory) Prof. MOK Vincent Chung Tong
莫仲棠
2011.533 Statins and White Matter Lesion Progression: A Randomized, Open-Label, Parallel-Group Study Prof. Mok Vincent Chung Tong
2012.552 Regression Of Cerebral Arteriosclerotic white matter lesion progression using Statins (ROCAS 2) study Prof Mok Vincent Chung Tong
2013.680 Cilostazol in Decreasing progression of cerebral white matter hyperintensities (DREAM) Prof. MOK Vincent Chung Tong
2011.611 Phase II of Pilot Study of Cognitive Registry at Acute Stroke Unit at Prince of Wales Hospital Prof. MOK Vincent Chung Tong
2022.374 Quantitative Neuroimaging Index for Early Detection of Dementia Prof. MOK Vincent Chung Tong
莫仲棠
2024.607 A Patient Registry for Early Detection and Management of Alzheimer’s Disease in Hong Kong Prof. MOK Vincent Chung Tong
2024.548 The BRaIn diseases, Fundus PhotoGrapHy and OCT (BRIGHT) Registry Prof. MOK Vincent Chung Tong
2024.549 Validation of the MRI-based Alzheimer’s Disease Resemblance Atrophy Index and Plasma-Based Biomarkers on Alzheimer’s Disease Prof. MOK Vincent Chung Tong
2008.083 Comparison and Characterisation of LRRK2 Mutations and Phenotypic Features Between Northern and Southern Chinese Parkinson's Disease Patients Prof Mok Vincent, Chung Tong
2015.303 Factors determining the uptake of influenza vaccine among children with chronic medical conditions Ms. MOK Yin Ki
莫燕琪
2020.489 Effectiveness of family-focused dyadic psychoeducational intervention (FDPEI) for stroke survivors and family caregivers on functional and psychosocial well-being: A randomised controlled trial Ms. MOU Huanyu
2024.041 Effects of Dyadic Motivational Interviewing (MI-Dyad) Program for Improving Activity Participation of Stroke Survivors and Family Caregivers: A Mixed-Methods Feasibility Study Ms. MOU Huanyu
牟焕玉
2016.424 How Diet Affect the Growth in Infants with Biliary Atresia: Breastfeed versus Artificial Formula Feed Dr. MOU Jennifer Wai Cheung
2020.335 20-Year Review of Abdominal Neuroblastoma in a Tertiary Centre Dr. MOU Jennifer Wai Cheung
2013.491 Assessing impact of CYP2B6-G516T polymorphisms on plasma efavirenz levels in Chinese HIV-positive patients using a pharmacokinetic model. Is there scope to individualise patient therapy? Dr Naftalin Claire
2017.338 The Validation and Applicability of the Chinese Version of the Patient Dignity Inventory in a Hong Kong Palliative Care Setting Dr. NATARAJAN Deepa
2019.081 Acceptance and commitment therapy for managing psychological distress and improving quality of life in patients with advanced cancer: a pilot one group pretest-posttest study Dr. NATARAJAN Deepa
2019.539 Eating-related distress and depression in advanced cancer patients with anorexia-cachexia symptoms: A cross-sectional survey Dr. NATARAJAN Deepa
2018.088 Price of vaccines not in Hong Kong's Childhood Immunisation Programme: effect on financing models and cost-effectiveness Prof. NELSON E. Anthony S.
2018.095 Assessing the Perceived Benefits of Establishing a Vaccine Pooled Procurement Mechanism for the Western Pacific Region Prof. NELSON E. Anthony S.

Page 174 of 265.